These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19246733)

  • 1. Lack of interaction between the peptidomimetic substrates captopril and cephradine.
    Foster DR; Yee S; Bleske BE; Carver PL; Shea MJ; Menon SS; Ramachandran C; Welage LS; Amidon GL
    J Clin Pharmacol; 2009 Mar; 49(3):360-7. PubMed ID: 19246733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
    Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).
    Zhang TT; Song M; Hang TJ; Xu XF; Wen AD; Yang L; Jia L
    J Clin Pharm Ther; 2009 Jun; 34(3):345-54. PubMed ID: 19646081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of captopril carboxyl ester derivatives for percutaneous absorption.
    Gullick DR; Ingram MJ; Pugh WJ; Cox PA; Gard P; Smart JD; Moss GP
    J Pharm Pharmacol; 2009 Feb; 61(2):159-65. PubMed ID: 19178762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine does not alter free unchanged captopril pharmacokinetics and biological effects in healthy volunteer.
    Richer C; Bah M; Cadilhac M; Thuillez C; Giudicelli JF
    J Pharmacol; 1986; 17(3):338-42. PubMed ID: 3025525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF; Pessa LR; Tanus-Santos JE
    Eur J Pharmacol; 2009 Apr; 607(1-3):173-7. PubMed ID: 19233159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
    Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
    Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interactions of captopril with H2-receptor antagonists.
    Sultana N; Arayne MS; Quraish R
    Pak J Pharm Sci; 2007 Apr; 20(2):132-9. PubMed ID: 17416569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative prediction of oral absorption of PEPT1 substrates based on in vitro uptake into Caco-2 cells.
    Shimizu R; Sukegawa T; Tsuda Y; Itoh T
    Int J Pharm; 2008 Apr; 354(1-2):104-10. PubMed ID: 18276092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme.
    Tzakos AG; Naqvi N; Comporozos K; Pierattelli R; Theodorou V; Husain A; Gerothanassis IP
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5084-7. PubMed ID: 16889963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption of several beta-lactam antibiotics. V. Effect of amino beta-lactam analogues and dipeptides on the absorption of amino beta-lactam antibiotics.
    Iseki K; Iemura A; Sato H; Sunada K; Miyazaki K; Arita T
    J Pharmacobiodyn; 1984 Oct; 7(10):768-75. PubMed ID: 6520699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephradine antacids interaction studies.
    Arayne MS; Sultana N; Afzal M
    Pak J Pharm Sci; 2007 Jul; 20(3):179-84. PubMed ID: 17545100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
    Yamamoto D; Takai S; Miyazaki M
    Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dependence of the pharmacokinetics of captopril on the type of adaptation reactions in the organism].
    Udut VV; Khazanov VA; Gurto RV; Borodulina EV; Postnikova IuE
    Eksp Klin Farmakol; 2007; 70(3):36-9. PubMed ID: 17650631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
    Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M
    Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of ACE inhibiting in mealworms on ovarian composition and ecdysteroid amounts.
    Soltani-Mazouni N; Bouteldja D; Lemeire E; Smagghe G
    Commun Agric Appl Biol Sci; 2007; 72(3):623-7. PubMed ID: 18399495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of microinjection of angiotensin II and captopril into nucleus accumbens on morphine self-administration in rats.
    Hosseini M; Alaei HA; Headari R; Eslamizadeh MJ
    Indian J Exp Biol; 2009 May; 47(5):361-7. PubMed ID: 19579802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cephradine suspension infants and children.
    Ginsburg CM; McCracken GH
    Antimicrob Agents Chemother; 1979 Jul; 16(1):74-6. PubMed ID: 475377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.